Note: Apotex/Aveva Drug Delivery Systems's revenues are gauged from an analysis of company filings.
Apotex/Aveva Drug Delivery Systems's Income Statement (based on Industry Averages)
Apotex/Aveva Drug Delivery Systems P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Apotex/Aveva Drug Delivery Systems is developing and marketing.
Apotex/Aveva Drug Delivery Systems doesn't have any recent trademark applications, indicating Apotex/Aveva Drug Delivery Systems is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
GEL MATRIX Transdermal drug delivery patches for use in the treatment of smoking cessation, biologics, dermatology, diabetes, asthma, inflammation, hormone replacement therapy, irritable bowel syndrome, oncology, nutraceuticals, Parkinson's disease, pain management, hypertension, weight loss, cardiovascular disease, gastro-urinary disease, central nervous system disorders and female health maladies
04/15/2008
AVEVA Custom manufacture of transdermal drug delivery patches
02/04/2008
AVEVA DRUG DELIVERY SYSTEMS A NITTO DENKO COMPANY [ Custom manufacture of transdermal drug delivery patches ]
10/14/2003
See all trademarks and details in the Full Report.
Market Share of Apotex/Aveva Drug Delivery Systems's Largest Competitors
A competitive analysis shows these companies are in the same general field as Apotex/Aveva Drug Delivery Systems, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Apotex/Aveva Drug Delivery Systems.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Apotex/Aveva Drug Delivery Systems's Fastest Growing Competitors
These companies are in the same general field as Apotex/Aveva Drug Delivery Systems and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.
My Watch List
